19.500
+3,72%
2026-10-16
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -54.3% | +2838.6% | 2 / 3 | -66.2% | +36.96 pp | +1811.32 pp | +7.2% | 0.00 | 22.81 | 0,3 | −66,2% | 19,2 | −54,3% | 22.81 | 13.16 | +73,3% |
| Pts | 0 | 12 | 8 | 0 | 12 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 19.500 (close price on 2026-10-16)EPS (TTM): 854,9
Financial charts
1.Revenue & growth
VND bn0,28Q2/26
1.Revenue & growth
VND bn0,28Q2/26
2.Profit & growth
VND bn19,2Q2/26
3.Profit mix (Penman)
VND bn31,4Q2/26
4.Margins & cost structure
%14.2%Q2/26
5.Returns & cash cycle
% · days-5.0%Q2/26
6.Earnings quality & cash
VND bn-18,4Q2/26
7.Asset structure
VND bn471Q2/26
8.Funding & debt health
VND bn · times471Q2/26
9.Revenue backlog
VND bn1,67Q2/26
10.Valuation
times · %22,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %522Q2/26
Adjusted EPS growth, latest quarter
-54.3%
Average adjusted EPS growth, 3 quarters
168%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26